業績

Abe N, Oku K, Amengual O, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Mori R, Morishita E, Suzuki-Inoue K, Atsumi T.

Potential therapeutics for antiphospholipid antibody associated thrombocytopenia: a systematic review and meta-analysis.

Mod Rheumatol. 2018 Dec 17:1-21.

Karino K, Fujieda Y, Kawamura T, Abe N, Shimoyama S, Kono M, Kato M, Yasuda S, Atsumi T.

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker": A case report.

Medicine (Baltimore). 2018 Dec;97(49):e13563. 

PMID: 30544475

Hisada R, Kato M, Ohnishi N, Sugawara E, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T.

Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus.

Rheumatology (Oxford). 2018

PMID: 30521019

Ohnishi N, Fujieda Y, Hisada R, Nakamura H, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T.

Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome.

Rheumatology (Oxford). 2018 Nov 30.

PMID: 30508199

Kaneko Y, Kato M, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Takeuchi T; SURPRISE study group.

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).

Ann Rheum Dis. 2018 Sep;77(9):1268-1275.

PMID: 29853455

Kono M, Yoshida N, Maeda K, Skinner NE, Pan W, Kyttaris VC, Tsokos MG, Tsokos GC.

Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9288-9293. 

PMID: 30150402

Karampetsou MP, Comte D, Suárez-Fueyo A, Katsuyama E, YoshidaN, Kono M, Kyttaris VC, Tsokos GC.

SLAMF1 engagement inhibits T cell-B cell interaction and diminishes IL-6 production and plasmablast differentiation in systemic lupus erythematosus.

Arthritis Rheumatol. 2018 Jul 29. 

PMID: 30058241

Maeda K, Otomo K, Yoshida N, Abu-Asab MS, Ichinose K, Nishino T, Kono M, Ferretti A, Bhargava R, Maruyama S, Bickerton S, Fahmy TM, Tsokos MG, Tsokos GC.

CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.

J Clin Invest. 2018 Aug 1;128(8):3445-3459.

PMID: 29985166

Kono M, Yoshida N, Maeda K, Tsokos GC

Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2478-2483.

PMID: 29463741 

Fujieda Y, Mader S, Jeganathan V, Arinuma Y, Shimizu Y, Kato M, Oku K, Minami A, Shimizu C, Yasuda S, Atsumi T.

Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.

Int J Rheum Dis. 2018 Oct 24.

PMID: 30358102